Oviva Therapeutics is a biotechnology company driving forward R&D in women's health and ovarian physiology with an aim to improve healthspan in women. They are currently in advanced preclinical stage for a therapeutic targeting protection of the ovarian reserve and extension of ovarian function.


Biotechnology

Research

Oviva Therapeutics

Daisy Robinton

Rachel Rubin

Oviva Therapeutics was founded by a team with a long history of experience in the medical and scientific industries. The team includes individuals who have worked as directors, fellows, lecturers, postdoctoral fellows, and professors at various institutions, including Harvard University, William Randolph Hearst Fellow, UCLA, HC70A: Genetic Engineering in Medicine, Agriculture and Law, Boston Children's Hospital, and Harvard Medical School. The team also has a wealth of experience in research, including cellular and molecular medicine, pediatric surgical research laboratories, and more.

Founding Team

About

Team members

Other teams at Oviva Therapeutics

Board of Directors

Leadership Team